Cognition Therapeutics Inc (CGTX) stock
CGTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.60−0.03 (-4.75%)
Close on Nov 18, 2026Market cap $57.06MP/E –Yield –
Cognition Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Cognition Therapeutics's market cap was $64.38M on Nov 11, 2026, against $153.59M a year earlier. Over the last 5 years it ranged from $2.71M to $157.86M, with a median of $56.27M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $64.38M | -46.0% |
| 2025 | Dec 31, 2025 | $119.16M | +316.4% |
| 2024 | Dec 31, 2024 | $28.62M | -49.1% |
| 2023 | Dec 29, 2023 | $56.27M | +11.8% |
| 2022 | Dec 30, 2022 | $50.34M | +1193.1% |
| 2021 | Dec 31, 2021 | $3.89M | – |
See a number that looks wrong?